BackOrchestra BioMed Holdings Overview

Orchestra BioMed Holdings Long Term Debt

Track Orchestra BioMed Holdings's long-term debt ($21M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$20.96M
↑ 689.23% YoYΔ $18.31M vs prior year quarter

Peer trimmed avg / median

Loading

Orchestra BioMed Holdings Long Term Debt History

Loading

Orchestra BioMed Holdings vs. peers: Long Term Debt Comparison

Loading

Orchestra BioMed Holdings Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orchestra BioMed Holdings (OBIO) FAQ

As of the most recent data (June 2026), OBIO shows a long-term debt of $21M. That compares with $2.7M in the prior-year period — up 689.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OBIO's long-term debt is now $21M (was $2.7M) — a 689.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orchestra BioMed Holdings is outperforming or lagging.

Tracking OBIO's long-term debt over time shows whether Orchestra BioMed Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $2.7M in the prior-year period — up 689.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $21M) with ownership activity and broader fundamentals.